{
  "chapter": "Respiratory System-Obstructive Lung Disease",
  "questions": [
    {
      "q_no": 1,
      "question": "A 20-year-old male presented with cough and breathing difficulty and was diagnosed with emphysema after radiographic examination. Which of the following genetic conditions should be suspected as a possible cause?",
      "options": {
        "A": "Cystic fibrosis",
        "B": "Asthma",
        "C": "Alpha-1 antitrypsin deficiency",
        "D": "Bronchiectasis"
      },
      "correct_answer": "C",
      "explanation": "Correct answer: C) Alpha-1 antitrypsin deficiency Explanation: Alpha-1 antitrypsin deficiency is a genetic condition characterized by low levels or dysfunctional alpha-1 antitrypsin protein. Alpha-1 antitrypsin deficiency: It is an autosomal recessive disorder caused by mutations in the alpha-1 antitrypsin gene located on Chromosome 14 . Normal individuals have the PiMM genotype , while those with the disease have the PiZZ genotype. This results in significantly reduced levels of functional alpha-1 antitrypsin protein. Carriers possess the PiMZ genotype. The condition primarily affects the lungs, leading to panacinar emphysema and the liver, causing cirrhosis due to abnormal protein accumulation. Cystic fibrosis (Option A) is a genetic disorder caused by CFTR gene mutations, leading to thick mucus, chronic lung infections, and bronchiectasis. While it causes obstructive lung disease, emphysema is not typical. Asthma (Option B) is a chronic inflammatory condition causing reversible airway obstruction and episodic wheezing, coughing, and breathlessness. It does not typically result in emphysema or structural lung damage. Bronchiectasis (Option D) is a condition of permanently dilated bronchi due to chronic infections or inflammation. While it causes cough and sputum production, it does not primarily lead to emphysema. Reference: Robbins and Cotran Pathologic Basis of Disease, 10th Edition, Pages 679, 680",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Respiratory System-Obstructive Lung Disease"
    },
    {
      "q_no": 2,
      "question": "Match the following types of emphysema with their characteristic features: Types of Emphysema Characteristic Features 1) Centriacinar emphysema A) Uniformly affects the entire acinus, commonly associated with alpha 1 antitrypsin deficiency 2) Panacinar emphysema B) Predominantly involves the upper lobes, often associated with bullae formation. Alveolar ducts and sacs are spared 3) Paraseptal emphysema inflammation or recurrent infections 4) Irregular emphysema D) Involves the distal airways and is often associated with spontaneous pneumothorax",
      "options": {
        "C": "1-a, 2-b, 3-c, 4-d",
        "A": "1-a, 2-c, 3-b, 4-d",
        "B": "1-b, 2-a, 3-d, 4-c",
        "D": "1-d, 2-b, 3-a, 4-c"
      },
      "correct_answer": "B",
      "explanation": "Correct answer: B) 1-b, 2-a, 3-d, 4-c Explanation: Emphysema is classified according to its anatomic distribution within the lobule. Based on the segments of the respiratory units that are involved, emphysema is subdivided into four major types: Features Centriacinar (M/C) Panacinar Paraseptal Irregular Involves Proximal acinus Proximal & distal acini Distal acinus Irregular involvement Site Upper lobes especially apical segments Lower zones & anterior margins of the lung. More severe at the base of the lung. The upper half of the lungs (more severe). Airspaces can form cyst-like structures. Any part of the lung can be involved. Aetiology Smokers Chronic bronchitis α 1-antitrypsin deficiency Spontaneous pneumothorax Depends on involvement, most found in autopsy The image below shows centriacinar emphysema. The image below shows paraseptal emphysema.",
      "image": null,
      "explanation_image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxpathology/Respiratory_System-Obstructive_Lung_Disease_Q2_exp.jpg",
      "chapter_heading": "Respiratory System-Obstructive Lung Disease"
    },
    {
      "q_no": 3,
      "question": "Which of the following mechanisms is not involved in the development of emphysema? response.",
      "options": {
        "A": "Toxic injury and inflammation leading to variable degrees of parenchymal destruction.",
        "B": "Protease-antiprotease imbalance with a relative deficiency of protective antiproteases.",
        "C": "The presence of T and B cells in affected parts of the lung indicates a robust adaptive immune",
        "D": "Oxidative stress induced by substances in tobacco smoke, alveolar damage, and inflammatory cells."
      },
      "correct_answer": "C",
      "explanation": "adaptive immune response. Correct answer : C) The presence of T and B cells in affected parts of the lung indicates a robust adaptive immune response. Explanation: Chronic inflammation in emphysema does lead to the accumulation of T and B cells in affected parts of the lung, but the role of adaptive immunity is currently uncertain. Therefore, it's not considered a defining feature of the disease. Pathophysiology of emphysema: Inhaled cigarette smoke and other noxious particles cause damage to respiratory epithelium and inflammation, resulting in parenchymal destruction, which is a hallmark of emphysema. In patients with emphysema, there is often a relative deficiency of protective antiproteases, which allows proteases released from inflammatory cells and epithelial cells to break down connective tissue components, contributing to tissue destruction. Substances in tobacco smoke, alveolar damage, and inflammatory cells all produce oxidants, which contribute to tissue damage, endothelial dysfunction, and inflammation, further exacerbating the pathology of emphysema. Reference: Robbins and Cotran Pathologic Basis of Disease, 10th Edition, Page 680",
      "image": null,
      "explanation_image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxpathology/Respiratory_System-Obstructive_Lung_Disease_Q3_exp.png",
      "chapter_heading": "Respiratory System-Obstructive Lung Disease"
    },
    {
      "q_no": 4,
      "question": "A 65-year-old man has been a heavy smoker for the past 40 years and presents with complaints of progressive shortness of breath, especially with exertion, and a chronic cough with occasional scanty sputum production. Physical examination reveals a barrel-shaped chest, decreased breathing sounds, and a prolonged expiratory phase. Based on the clinical presentation and history, what is the most likely diagnosis?",
      "options": {
        "A": "Chronic bronchitis",
        "B": "Emphysema",
        "C": "Pulmonary fibrosis",
        "D": "Asthma"
      },
      "correct_answer": "B",
      "explanation": "Correct answer: B) Emphysema Explanation: The patient's history of heavy smoking, chronic cough with occasional scanty sputum production , progressive shortness of breath, especially with exertion and physical examination showing barrel-shaped chest, decreased breath sounds, and a prolonged expiratory phase is highly suggestive of COPD with emphysema. Clinically significant emphysema is largely confined to smokers and patients with α 1-antitrypsin deficiency. Clinical features: The classical presentation of emphysema involves a barrel-shaped chest and dyspnea, with obviously prolonged expiration, sitting forward in a hunched-over position, and breathing through pursed lips . Cough is often slight, overdistention of the lungs is severe, diffusion capacity is low, and blood gas values are relatively normal at rest. Weight loss is common and can be so severe as to suggest an occult cancer. Chronic bronchitis (Option A) presents insidiously with slowly increasing dyspnea on exertion and chronic cough with sputum production, slight at first but increasing over time. The most important diagnostic test is spirometry, which typically shows an FEV1/FVC ratio of less than 0.7. The main clinically distinguishing factor between emphysema and chronic bronchitis is that chronic bronchitis is characterized by a persistent, mucus-producing cough. In contrast, the primary symptom of emphysema is shortness of breath . Bronchitis Emphysema Age (years) 40–45 50–75 Dyspnea Mild; late Severe; early Cough Early; copious sputum Late; scanty sputum Infections Common Occasional Respiratory insufficiency Early, periodic End-stage, unremitting Cor pulmonale Common Uncommon, end-stage Airway resistance Increased Normal or slightly increased Elastic recoil Normal Low Chest radiograph Prominent vessels; large heart size Hyperinflation; normal heart size Appearance Blue bloater Pink puffer Pulmonary fibrosis (Option C) is characterized by progressive scarring of the lungs, leading to decreased lung compliance and restrictive lung disease. The chest X-ray findings of hyperinflated, hyperlucent lungs are not consistent with pulmonary fibrosis. Asthma (Option D) is characterized by reversible airflow obstruction, wheezing, and chest tightness, but the patient's history of heavy smoking and clinical presentation is not typical of asthma. Reference: Robbins and Cotran Pathologic Basis of Disease, 10th Edition, Page 679",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Respiratory System-Obstructive Lung Disease"
    },
    {
      "q_no": 5,
      "question": "A 45-year-old male patient presents with a history of chronic cough, increased sputum production, and shortness of breath. He reports that these symptoms have been present for several years and have gradually worsened over time. The patient is a lifelong smoker, having smoked one pack of cigarettes per day for the past 20 years. What is the likely diagnosis?",
      "options": {
        "A": "Emphysema",
        "B": "Asthma",
        "C": "Chronic bronchitis",
        "D": "Lung cancer"
      },
      "correct_answer": "C",
      "explanation": "Correct answer: C) Chronic bronchitis Explanation: The patient's symptoms of chronic cough, increased sputum production, and shortness of breath, combined with his history of long-term smoking, are highly suggestive of chronic bronchitis. Chronic bronchitis is a type of chronic obstructive pulmonary disease (COPD) characterized by persistent cough and mucus production. The critical diagnostic criteria for chronic bronchitis are cough and sputum production for at least 3 months per year for two consecutive years without any other identifiable cause. This distinguishes chronic bronchitis from acute bronchitis, which is a temporary condition. Cause of chronic bronchitis: Smoking Air pollution Occupational exposures (dust, chemicals, fumes) Recurrent respiratory infections Indoor biomass fuel exposure Chronic exposure to environmental irritants Pathogenesis: Longstanding bronchitis commonly leads to pulmonary hypertension, cor pulmonale, and death due to heart failure. Treatment options include smoking cessation, oxygen therapy, long-acting bronchodilators with inhaled corticosteroids, antibiotics, and physical therapy. Emphysema (Option A): Characterized by the destruction of the alveoli in the lungs, leading to airflow obstruction. While emphysema can co-occur with chronic bronchitis, the patient's primary symptoms of chronic cough and increased sputum production indicate more chronic bronchitis. Asthma (Option B): Characterized by intermittent symptoms that worsen with triggers rather than the persistent, progressive symptoms described in the case. Lung cancer (Option D): Lung cancer can also present with cough and shortness of breath, but the gradual, chronic nature of the patient's symptoms makes lung cancer a less likely diagnosis compared to chronic bronchitis.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Respiratory System-Obstructive Lung Disease"
    },
    {
      "q_no": 6,
      "question": "Which of the following is not true regarding chronic bronchitis? chest tightness.",
      "options": {
        "A": "Reid index >0.4",
        "B": "The most common cause is smoking",
        "C": "The most common cause of exacerbation is Haemophilus influenzae.",
        "D": "Recurrent, episodic attacks of wheezing, prolonged expiration, dyspnea (shortness of breath), and"
      },
      "correct_answer": "D",
      "explanation": "(shortness of breath), and chest tightness. Correct answer: D) Recurrent, episodic attacks of wheezing, prolonged expiration, dyspnea (shortness of breath), and chest tightness. Explanation: Recurrent, episodic attacks of wheezing, prolonged expiration, dyspnea (shortness of breath), and chest tightness are seen in asthma. Chronic bronchitis is defined clinically as persistent cough with sputum production for at least 3 months in at least 2 consecutive years in the absence of any other identifiable cause. Reid's Index: RI = Thickness of submucosal gland layer / overall thickness of the wall The Reid index ( normally 0.4 ) is increased in chronic bronchitis (>0.4), usually in proportion to the severity and duration of the disease. Histopathology: Chronic inflammation of the airways (predominantly lymphocytes and macrophages). Thickening of the bronchiolar wall due to smooth muscle hypertrophy. Deposition of extracellular matrix in the muscle layer. Peribronchial fibrosis. Goblet cell hyperplasia. Enlargement of the mucus-secreting glands of the trachea and bronchi. The most striking change is an increase in the size of the mucous glands. This increase can be assessed by the Reid index. The primary or initiating factor in the genesis of chronic bronchitis is exposure to noxious or irritating inhaled substances such as tobacco smoke (90% of those affected are smokers, making it the commonest cause) and dust from grain, cotton, and silica. (Option B) The most common cause of exacerbation in COPD is Haemophilus influenzae and the second most common cause is Moraxella. (Option C) Reference: Robbins and Cotran Pathologic Basis of Disease, 10th Edition, Page 681",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Respiratory System-Obstructive Lung Disease"
    },
    {
      "q_no": 7,
      "question": "A 32-year-old female presents with recurrent episodes of wheezing, coughing, and shortness of breath. On further testing, a diagnosis of asthma was made. Which of the following best describes the underlying pathophysiological changes seen in this patient's condition?",
      "options": {
        "A": "Reduced goblet cell secretion",
        "B": "Thinning of the basement membrane",
        "C": "Increase in airway inflammation and remodeling",
        "D": "Decreased submucosal gland activity"
      },
      "correct_answer": "C",
      "explanation": "Correct answer: C) Increase in airway inflammation and remodelling Explanation: The clinical presentation of recurrent wheezing, coughing, and shortness of breath suggests airway inflammation and remodelling , which are characteristic of asthma. These changes contribute to airway hyperresponsiveness and the symptoms experienced by the patient. Pathophysiology of Asthma: Atopic asthma , the most common form of the disease, is caused by a Th2-mediated IgE response to environmental allergens in genetically predisposed individuals. (Type 1 hypersensitivity) Airway inflammation is central to the disease pathophysiology and causes airway dysfunction partly through the release of potent inflammatory mediators and partly through the remodelling of the airway wall. As the disease becomes more severe, there is increased local secretion of growth factors, which induce mucous gland enlargement , smooth muscle proliferation , angiogenesis , and fibrosis . Pathophysiology of Asthma\" data-author=\"NA\" data-hash=\"6953\" data-license=\"NA\" data-source=\"NA\" data-tags=\"April2025\" height=\"471\" src=\"https://image.prepladder.com/notes/nnfZ8IQ4tQ8Y4LD2GvW81743674820.png\" width=\"500\" /> Images A & B Comparison of a normal airway and an airway involved in asthma. The asthmatic airway is marked by the accumulation of mucus in the bronchial lumen secondary to Increase in the number of mucus-secreting goblet cells in the mucosa (Option A) Hypertrophy of submucosal glands (Option D) , intense chronic inflammation due to the recruitment of eosinophils, macrophages, and other inflammatory cells. The basement membrane is thickened (Option B), and there is hypertrophy and hyperplasia of smooth muscle cells. Image C Inhaled allergens (antigen) elicit a Th2-dominated response favouring IgE production and eosinophil recruitment. Image D On re-exposure to antigen, the immediate reaction is triggered by antigen-induced cross-linking of IgE bound to Fc receptors on mast cells. These cells release preformed mediators that directly and via neuronal reflexes induce bronchospasm , increased vascular permeability , mucus production , and leukocyte recruitment. Image E Leukocytes are recruited to the site of the reaction (neutrophils, eosinophils, and basophils. Lymphocytes and monocytes release additional mediators that initiate the late-phase reaction. Several factors released from eosinophils (e.g., major basic protein , eosinophil cationic protein ) also cause damage to the epithelium. Reference: Robbins and Cotran Pathologic Basis of Disease, 10th Edition, Page 683",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Respiratory System-Obstructive Lung Disease"
    },
    {
      "q_no": 8,
      "question": "A 45-year-old male has a history of recurrent wheezing, coughing, and shortness of breath. His sputum microscopy, shown in the image below, reveals the following finding. Which best describes this finding?",
      "options": {
        "A": "Extrusion of mucus plugs from the subepithelial mucous gland ducts or bronchioles.",
        "B": "Ciliated columnar cells sloughed from the bronchial mucosa.",
        "C": "Polypoid plugs of loose organizing connective tissue within the bronchioles.",
        "D": "They are composed of Galectin 10."
      },
      "correct_answer": "D",
      "explanation": "Correct answer : D) They are composed of Galectin 10. Explanation : The clinical presentation points towards a diagnosis of bronchial asthma, with sputum culture showing Charcot-Leyden crystals Charcot-Leyden crystals: They are microscopic, needle-shaped crystals that are often found in the sputum of asthma patients, particularly during exacerbations . They are primarily composed of galectin-10 ( derived from the eosinophils) also known as Charcot-Leyden crystal protein (CLC). Strong inducers of inflammation and mucus production. Extrusion of mucus plugs from the subepithelial mucous gland ducts or bronchioles describes the Curschmann spirals. They are a characteristic finding in asthma. (Option A) Ciliated columnar cells sloughed from the bronchial mucosa describe the Creola bodies seen in bronchial asthma. (Option B) Polypoid plugs of loose organizing connective tissue within the bronchioles, alveolar ducts, and alveoli describe Masson bodies , which are seen in cryptogenic organising pneumonia. (Option C)",
      "image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxpathology/Respiratory_System-Obstructive_Lung_Disease_Q8_q.jpg",
      "explanation_image": null,
      "chapter_heading": "Respiratory System-Obstructive Lung Disease"
    },
    {
      "q_no": 9,
      "question": "A 30-year-old patient presents with a history of recurrent wheezing, coughing, and shortness of breath. Upon further investigation, it is found that the patient has a family history of allergies and asthma. Which genetic factor is most likely co-related to the severity of this condition?",
      "options": {
        "A": "Variant IL-4 receptor gene",
        "B": "IL-13 polymorphism",
        "C": "ADAM33 polymorphism",
        "D": "YKL40 gene mutation"
      },
      "correct_answer": "D",
      "explanation": "Correct answer : D) YKL40 gene mutation Explanation : The YKL40 (a chitinase-like glycoprotein) gene mutation has been found to be correlated with the severity of asthma. YKL40 levels are associated with inflammation and tissue remodelling in the airways, contributing to the progression and severity of asthma symptoms. Genetic Factors in Asthma: A susceptibility locus for asthma located on chromosome 5q , near the gene cluster, encoding the cytokines IL-3, IL-4, IL-5, IL-9, and IL-13 and the IL-4 receptor. Polymorphisms in the IL13 gene have the strongest and most consistent associations with asthma or allergic disease. The IL-4 receptor gene variants are associated with atopy , elevated total serum IgE , and asthma. Variants associated with the genes encoding IL-33 ADAM33 polymorphism. Reference: Robbins and Cotran, Pathological Basis of Disease, 10th Edition, Page 684",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Respiratory System-Obstructive Lung Disease"
    },
    {
      "q_no": 10,
      "question": "A 35-year-old male presents to the emergency department with complaints of chronic cough with production of purulent sputum, intermittent hemoptysis, and recurrent respiratory infections over the past several years. He reports a history of childhood respiratory infections and no significant past medical history. Physical examination reveals coarse crackles and rhonchi on auscultation of the chest. Chest X-ray shows bilateral bronchial wall thickening and tram-line shadows. Which of the following is unlikely to be a cause for this condition?",
      "options": {
        "A": "Primary ciliary dyskinesia",
        "B": "Bronchial Asthma",
        "C": "Cystic fibrosis",
        "D": "Kartagener syndrome"
      },
      "correct_answer": "B",
      "explanation": "Correct answer : B) Bronchial Asthma Explanation: The clinical findings along with radiographic findings are suggestive of bronchiectasis and bronchial asthma is not a cause. Bronchiectasis is the permanent dilation of the bronchi and bronchioles. Aetiology of Bronchiectasis: Congenital or hereditary conditions (Options A, C, and D) Cystic fibrosis Primary ciliary dyskinesia Kartagener syndrome Severe necrotising pneumonia Caused by bacteria, viruses, or fungi This may be a single severe episode or recurrent infection Bronchial obstruction Tumor Foreign body Idiopathic (50% of the cases) Dysfunctional host immunity to infectious agents leads to chronic inflammation Reference: Robbins and Cotran Pathologic Basis of Disease, 10th Edition, Pages 687, 688",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Respiratory System-Obstructive Lung Disease"
    },
    {
      "q_no": 11,
      "question": "Which of the following statements accurately describes the pathophysiology of Kartagener's syndrome?",
      "options": {
        "A": "Mutation in the CFTR gene leading to impaired ciliary function.",
        "B": "Autosomal dominant inheritance pattern affecting the cilia in the respiratory tract.",
        "C": "The primary defect involves dynein arm proteins, leading to impaired ciliary motility.",
        "D": "Characterized by an excess of cilia in the respiratory epithelium."
      },
      "correct_answer": "C",
      "explanation": "motility. Correct answer : C) The primary defect involves dynein arm proteins, leading to impaired ciliary motility. Explanation : Kartagener’s syndrome is a rare genetic disorder that is part of the broader spectrum of primary ciliary dyskinesia (PCD). The primary defect lies in the dynein arm proteins; there is impaired ciliary motility. This impairment leads to ineffective clearance of mucus, debris, and pathogens from the respiratory tract, sinuses, and other ciliated surfaces in the body. Kartagener’s syndrome is characterised by a triad of: Bronchiectasis. Situs inversus Sinusitis. Infertility can be seen in males due to sperm dysmotility (Asthenospermia). Mutation in the CFTR gene leading to impaired ciliary motility (Option A): Cystic fibrosis is a genetic disorder caused by CFTR gene mutations, leading to thick mucus buildup in the lungs and digestive system. Autosomal dominant inheritance pattern affecting the cilia in the respiratory tract (Option B): Kartagener's syndrome follows an autosomal recessive inheritance pattern, not autosomal dominant. Additionally, it affects the structure and function of cilia throughout the body, not just in the respiratory tract. Characterized by an excess of cilia in the respiratory epithelium (Option D): Kartagener's syndrome is characterized by defects in ciliary structure and function, leading to impaired ciliary motility rather than an excess of cilia. Reference: Robbins and Cotran, Pathological Basis of Disease, 10th Edition, Page 687",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Respiratory System-Obstructive Lung Disease"
    },
    {
      "q_no": 12,
      "question": "A 45-year-old male presents with a chronic cough productive of copious sputum. He reports frequent respiratory infections over the past several years. Physical examination reveals digital clubbing and coarse crackles on auscultation. An HRCT is done and shown below. Which of the following is the most likely diagnosis?",
      "options": {
        "A": "Tuberculosis",
        "B": "Asthma",
        "C": "Chronic obstructive pulmonary disease",
        "D": "Bronchiectasis"
      },
      "correct_answer": "D",
      "explanation": "Correct answer: D) Bronchiectasis Explanation : The clinical presentation of a male with chronic cough, copious sputum, past history of frequent respiratory infections, clubbing, coarse crackles on auscultation, and HRCT showing thickened and dilated bronchi (tram-track appearance) is suggestive of bronchiectasis. Bronchiectasis is characterised by the irreversible dilation and distortion of bronchi , typically due to chronic inflammation and recurrent infections. The image below shows bronchiectasis with markedly dilated bronchi in the upper and lower lobes. Tuberculosis (Option A): HRCT shows cavitary lesions, tree-in-bud nodules, or consolidations, not the bronchial dilation seen in bronchiectasis. Asthma (Option B): HRCT is usually normal or may show bronchial wall thickening but not bronchial dilation. COPD (Option C): HRCT shows emphysematous changes (air trapping, bullae) and airway narrowing but lacks the tram-track or signet ring appearance seen in bronchiectasis.",
      "image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxpathology/Respiratory_System-Obstructive_Lung_Disease_Q12_q.jpg",
      "explanation_image": null,
      "chapter_heading": "Respiratory System-Obstructive Lung Disease"
    }
  ]
}
